Atlas Trials

A Phase 2 Study of CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis

Clinical trial NCT04026997 · TERMINATED

Trial details

NCT number
NCT04026997
Sponsor
CinDome Pharma, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastroparesis
Start date
2019-09-11
Primary completion
2020-12-17
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.